|
Market Closed -
Nasdaq Stockholm
17:00:00 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 19.84 SEK | +2.69% |
|
-0.50% | -12.21% |
| 08-20 | SynAct Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-20 | Synact Pharma reports narrower operating loss | FW |
Chart: Technical Analysis
Stock exchange
Nasdaq Stockholm
SYNACT 19.84 kr
+2.69%
1.38M
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq Stockholm
| SYNACT | 19.84SEK | +2.69% | 1.38M kr | |
CBOE
| 19.80SEK | +3.02% | 134K kr | ||
Deutsche Boerse AG
| 8F8 | 1.756EUR | +0.80% | 0 € | |
Börse Stuttgart
| 8F8 | 1.768EUR | +2.79% | 0 € | |
CBOE
| 21.45SEK | 0.00% | 0 kr | ||
Tradegate
| 8F8 | 1.796EUR | +3.10% | 0 € | |
Boerse Muenchen
| 8F8 | 1.792EUR | +2.87% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 21.8 | 21.8 | 24.95 |
| Spread/Res. | -8.99% | -8.99% | -20.48% |
| Spread/Supp. | +15.62% | +36.45% | +70.15% |
| Support | 17.16 | 14.54 | 11.66 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SYNACT Stock
- Charts SynAct Pharma AB
Select your edition
All financial news and data tailored to specific country editions

















